J Kermanshah Univ Med Sci

Image Credit:J Kermanshah Univ Med Sci

Investigation of Cardiac Disorders in Infants with a History of Echogenic Focus on Fetal Echocardiography: A Cohort Study

Author(s):
Hooman DaryoushiHooman Daryoushi1, 2, 3, Zahra NaghibifarZahra NaghibifarZahra Naghibifar ORCID4, Armin NaghipourArmin NaghipourArmin Naghipour ORCID3, 1, 2, Amirhossein SahebkarAmirhossein SahebkarAmirhossein Sahebkar ORCID5, Samin AmiriSamin AmiriSamin Amiri ORCID6,*
1Clinical Research Development Center, Mohammd Kermanshahi Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Clinical Research Development Center, Farabi Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3Clinical Research Development Center, Imam Khomeini Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Infectious Diseases Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
6School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Kermanshah University of Medical Sciences:Vol. 29, issue 4; e166287
Published online:Nov 22, 2025
Article type:Letter
Received:Sep 13, 2025
Accepted:Nov 18, 2025
How to Cite:Daryoushi H, Naghibifar Z, Naghipour A, Sahebkar A, Amiri S. Investigation of Cardiac Disorders in Infants with a History of Echogenic Focus on Fetal Echocardiography: A Cohort Study.J Kermanshah Univ Med Sci.2025;29(4):e166287.https://doi.org/10.5812/jkums-166287.

Abstract

Background and Objectives:

The echogenic fetal heart is a bright spot observed in ultrasound examinations of the fetus. The present study aimed to investigate cardiac disorders in neonates with a history of echogenic focus on fetal echocardiography.

Methods:

The present study was conducted as a cohort study in pregnant women who were referred for echocardiography between 2017 - 2023. In this time period, 926 pregnant women were referred to Dr. Mohammad Kermanshahi Hospital, and only 100 pregnant women whose fetuses had fetal heart echogenic focus during pregnancy and met the study criteria were included in the study as a census. The data collection tool was a checklist developed by the researchers.

Results:

The results showed that no cardiac abnormalities were reported for any of the babies, and 36 days after birth, the fetal heart echogenic focus disappeared. The findings indicated that the prevalence of fetal heart echogenic focus in the right ventricle, left ventricle and both ventricles was 46.0% (n = 46), 29.0% (n = 29), and 25.0% (n = 25), respectively.

Conclusions:

Fetal heart echogenic foci, particularly when the right ventricle is involved, seem to be a poor prognostic sign of congenital cardiac abnormalities.

1. Background

One of the most important and evolving topics in pediatric cardiology is the fetal heart (1). The possibility of high-quality and detailed images of the anatomy of the heart became possible with the advancement of ultrasound technology (2) that enabled capturing images of the developing heart of the fetus with high resolution. Currently, congenital heart disease in babies and children is diagnosed using this method (3). On the other hand, fetal echocardiography between 18 - 22 weeks of pregnancy can detect congenital heart diseases (CHD) in fetus with a high sensitivity (2). Fetal echocardiography is a completely non-invasive and harmless diagnostic method, and the most suitable tool for diagnosing structural abnormalities of the heart including CHD and echogenic heart (1). The CHD is one of the most common congenital abnormalities in infants and children (4). Based on the results of the previous studies, 6 - 9 out of every 1000 live babies have CHD (5). As the heart defects are associated with significant complications and mortality in fetuses and infants, one of the most important measures during pregnancy is to diagnose fetal CHD before birth (6). Most CHDs can be detected in utero during the second or even late first trimester with a detection rate of 85 - 95% in specialized departments. One of the weak soft markers of CHD in newborns is the presence of an echogenic focus in the ventricular heart (4). The intracardial echogenic focus of the fetus (ICEF) is defined as a type of benign complication without clinical symptoms (7). Echogenic diagnosis is made with the observation of a bright spot in the heart muscle during the ultrasound examination of the fetus (8). The incidence of ICEF has been reported to be between 30 - 86 % (9). The most common place for the ICEF Index is the left ventricle of the fetus heart (7). Based on the results of previous studies and clinical experiences, the echogenic focus represents mineralization or small deposits of calcium in the heart muscle (9). Therefore, physiological changes during pregnancy are obvious for the adaptation of the mother and the nutritional needs of the fetus (8). Considering the conflicting results obtained in pathogenesis studies, the reported findings need further investigation.

The findings of a number of previous studies have shown that the presence of ICEF does not cause structural or functional problems in the heart (10-12). However, some other echocardiography studies of newborns have shown the continuation of the echogenic focus inside the heart and subsequent congenital diseases of newborns (7, 13). Additionally, some studies have shown that in 20 - 90% of cases, ICEF disappears inside the heart of newborns (14).

2. Objectives

Considering the contradiction between the results of previous studies, the present study was undertaken in pregnant women to explore the association between ICEF and CHD.

3. Methods

3.1. Study Design and Participants

The study population of the current Cohort study consisted of pregnant women whose fetuses were affected by intracardiac echogenic focus.

3.2. Data Collection

The pregnant women who were referred to Dr. Mohammad Kermanshah Hospital Clinic, Kermanshah, Iran, for fetal echocardiography during 2017 - 2023, and had definitive diagnosis of the echogenic center inside the fetal heart. Pregnant women were selected during 7 years. Echocardiography was performed by a Samsung Ws80 device, manufactured in South Korea in 2015, by a pediatric cardiologist.

Each pregnant woman was examined during 9 months of pregnancy between the 18th and 22nd week of their fetus. After delivery, their babies were followed up until the 36th day after birth.

3.3. Inclusion and Exclusion Criteria

Inclusion criteria were as follows: (1) The ultrasound anomaly scan was normal; (2) none of the other soft markers, such as echogenic intestine, were present; (3) the axis of the heart was normal; and (4) the four-chamber view of the heart was normal. The exclusion criteria included: (1) The parents had a history of CHD; (2) kidney function and calcium levels were not normal; (3) an echogenic focus scan had not been performed between weeks 18 and 22; (4) control echocardiography was not performed after birth until the 36th day; and (5) the mother’s kidney function was abnormal.

3.4. Data Collection Tool

The data collection tool in the present study was a researcher-made checklist. The checklist includes the mother’s demographic information such as weight (kg), height (cm), Body Mass Index (BMI), mother’s age (years), delivery age (years), and pregnancy information including: Mother’s turn of pregnancy (number), abortion history (number), age of fetal examination (weeks), location of echogenic focus of the fetal heart (right, left, both), and delivery data time of newborn cardiac examination after birth (days), gender of the newborn (boy, girl), type of delivery (natural, cesarean), and congenital heart disease of the newborn (yes/no).

3.5. Statistical Analysis

Data analysis was performed after data collection and entry into STATA software version 17. To describe quantitative data, central indicators (mean, standard deviation) and to describe qualitative variables, frequency (percentage) were reported.

4. Results

Among the 926 women studied, 100 pregnant women whose fetuses had fetal heart echogenic foci during pregnancy and met the study criteria were selected using the using the census method. The minimum age of pregnancy was 16 years and the maximum age was 46 years. Overall, the average age of the included subjects was 32.1 ± 9.1 years. Based on the descriptive results, the average BMI was 30.9 ± 5.3. On average, the fetus was examined at 19.2 ± 1.2 weeks and the newborn at 38.2 ± 1.9 days for the echogenic state of the heart (Table 1).

Table 1.Descriptive Information Related to Quantitative Variables Studied (N = 100)
VariablesRangeMean ± SD
Age (y) 16 - 4632.1 ± 9.1
Weight (kg) 60 - 11681.3 ± 13.1
Height (cm)153 - 178162.5 ± 5.9
BMI22 - 4530.9 ± 5.3
Time of fetal cardiac echogenic examination (wk)18 - 2219.2 ± 1.2
Time of echogenic examination after birth (d)36 - 4138.2 ± 1.9

Abbreviation: BMI, Body Mass Index.

The results showed that 54.0% (n = 54) of the examined infants were boys and the rest were girls. Also, 28.0% of women (n = 28) experienced their first pregnancy and 20.0% (n = 20) had at least their fourth pregnancy. The findings indicated that 46.0% (n = 46) of the echogenic focus of the fetal heart was observed on the right side, 29.0% (n = 29) on the left side, and 25.0% (n = 25) on both sides. Therefore, 28.0% (n = 28) of the women had a history of one abortion and 7% (n = 7) had a history of two abortions. Additionally, 86% (n = 86) of women gave birth naturally and the rest were delivered by cesarean section. None of the examined infants who had an echogenic heart center during the fetal period had congenital heart disease after birth until the 36th day. Additionally, after 36-day postnatal follow-up, their cardiac echogenic focus disappeared (Table 2).

Table 2.Descriptive Information About Qualitative Variables Studied (N = 100)
VariablesNo. (%)
Sex
Boy54 (54.0)
Girl46 (46.0)
Mothers’ type of delivery
Natural86 (86.0)
Caesarean14 (14.0)
BMI a
Normal11 (11.0)
Abnormal89 (89.0)
Mother’s turn of pregnancy
First28 (28.0)
Second29 (29.0)
Third23 (23.0)
Fourth and more20 (20.0)
Abortion history
Never65 (65.0)
128 (28.0)
≥ 27 (7.0)
Congenital heart disease
Yes0 (00.0)
No100 (100.0)
Location of echogenic focus
Left29 (29.0)
Right46 (46.0)
Both25 (25.0)
Time of examination after birth (d)
< 531 (31.0)
5 - 10 69 (69.0)

Abbreviation: BMI, Body Mass Index.

a Normal Body Mass Index is 18.5 - 24.9. Abnormal was considered less than 18.5 and more than 24.9.

5. Discussion

The results of the present study showed that there was no association between ICEF and CHD. Also, after follow-up, the ICEF in infants disappeared. The results of studies by Huang et al. (10), Buyukkurt et al. (11), and Wrede et al. (12) showed that no abnormal cardiac structures were detected in subjects with ICEF. Additionally, the echogenic focus created in the fetus decreased or even disappeared as the week of pregnancy progressed. However, the results of the studies by Shakoor et al. (13) and Chiu et al. (7) showed a high prevalence of congenital heart disease defects in ICEF. Conflicting reports on the association of ICEF with CHD may be due to sample size or predefined inclusion and exclusion criteria in different studies. Therefore, according to the results of the current study, it is suggested that the echogenic focus be considered as a finding of low importance and without serious consequences in infants.

The results of the present study showed that the most common location for the formation of ICEF is the right ventricle of the fetus. However, studies by Wang et al. (15), Chiu et al. (7), Philip et al. (16), and Vahedian et al. (2) reported the most common site of formation of ICEF in the left ventricle of the fetus. Therefore, based on the results of the previous studies, cardiac echogenic focus has been observed mostly in the left ventricle. On the other hand, according to the results of previous studies, the appearance of echogenic focus in different organs of the fetus often indicates pathological findings or related diseases during prenatal ultrasound examination. Multiple echogenic foci or diffused echogenic foci in the fetal heart, especially when the right ventricle is involved, has been linked with other pathologies and may be a sign of poor prognosis (14).

The most important finding in this study was that none of the examined infants with an echogenic heart center during the fetal period showed signs of CHD on echocardiography up to the 36th day following birth. Additionally, the cardiac echogenic focus disappeared after the 36-day follow-up. Given these observations, the presence of multiple echogenic foci appears to be a poor prognostic marker for CHD, particularly when the fetal right ventricle is involved.

One of the limitations of the present study was the lack of examination of serum calcium level of pregnant mothers. Based on the results of previous studies, a direct and strong association between serum calcium levels and echogenicity exists. Therefore, it is suggested to investigate the relationship between serum calcium levels and echogenicity and its related factors in future studies.

Footnotes

References

  • 1.
    Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr. 2017;15(1):13-7. [PubMed ID: 27530200]. https://doi.org/10.1007/s12574-016-0308-2.
  • 2.
    Vahedian M, Yosefi M, Mohammadi A, Rezvan S, Noori E, Rezaei G, et al. [Evaluation of referral indications for fetal echocardiography in pregnant women referred to Echocardiography unit of Masoumeh Hospital in the winter of 2018]. Jundishapur Sci Med J. 2019;18(4):369-77. FA. https://doi.org/10.22118/jsmj.2019.196900.1784.
  • 3.
    Pike JI, Krishnan A, Donofrio MT. Early fetal echocardiography: congenital heart disease detection and diagnostic accuracy in the hands of an experienced fetal cardiology program. Prenat Diagn. 2014;34(8):790-6. [PubMed ID: 24706289]. https://doi.org/10.1002/pd.4372.
  • 4.
    Nair A, Radhakrishnan S. Evaluation of Referral Pattern for Fetal Echocardiography at a Tertiary Care Center in Northern India and Its Implications. J Obstet Gynaecol India. 2016;66(Suppl 1):258-62. [PubMed ID: 27651614]. [PubMed Central ID: PMC5016462]. https://doi.org/10.1007/s13224-016-0872-4.
  • 5.
    Moradi P, Naghibifar Z, Naghipour A. Incidence of Congenital Anomalies and Related Factors in Newborns: A Prospective Study. Congenital Heart Disease. 2025;20(1):77-87. https://doi.org/10.32604/chd.2025.061784.
  • 6.
    Bhagwat AR. Significance of Echogenic Cardiac Nodule in Fetus as Soft Marker. Int J Anatomy, Radiol Surg. 2017;6(2):64-7.
  • 7.
    Chiu G, Zhao A, Zhang B, Zhang T. Intracardiac echogenic focus and its location: association with congenital heart defects. J Matern Fetal Neonatal Med. 2019;32(18):3074-8. [PubMed ID: 30563390]. https://doi.org/10.1080/14767058.2018.1558200.
  • 8.
    Yarsilikal Guleroglu F, Balkan Ozmen A, Ekmez M, Cetin A. Relationship between Maternal Serum Calcium and Magnesium Levels and Isolated Fetal Echogenic Intracardiac Focus Encountered During Second-trimester Ultrasound Screening. Medical Bulletin of Haseki. 2022;60(1):40-4. https://doi.org/10.4274/haseki.galenos.2021.7841.
  • 9.
    Wang J, Chen L, Wang L, Yin D, Zeng Y, Tang F, et al. Segmental aneuploidies in fetuses with isolated echogenic intracardiac focus among women younger than 35 years. Sci Rep. 2020;10(1):10496. [PubMed ID: 32591622]. [PubMed Central ID: PMC7320167]. https://doi.org/10.1038/s41598-020-67501-9.
  • 10.
    Huang SY, Shaw SW, Cheuh HY, Cheng PJ. Intracardiac echogenic focus and trisomy 21 in a population previously evaluated by first-trimester combined screening. Acta Obstet Gynecol Scand. 2010;89(8):1017-23. [PubMed ID: 20521868]. https://doi.org/10.3109/00016349.2010.485631.
  • 11.
    Büyükkurt S, Arslan E, Sucu M, Özsürmeli M. Perinatal outcome of fetuses with echogenic intracardiac focus. Clin Experiment Obstet Gynecol. 2020;47(3):372–5. https://doi.org/10.31083/j.ceog.2020.03.5121.
  • 12.
    Wrede E, Knippel AJ, Verde PE, Hammer R, Kozlowski P. Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis. Ultrasound Int Open. 2019;5(3):E98-E106. [PubMed ID: 32159071]. [PubMed Central ID: PMC7062549]. https://doi.org/10.1055/a-1118-3974.
  • 13.
    Shakoor S, Ismail H, Munim S. Intracardiac echogenic focus and fetal outcome - review of cases from a tertiary care centre in Karachi, Pakistan. J Matern Fetal Neonatal Med. 2013;26(1):2-4. [PubMed ID: 22708618]. https://doi.org/10.3109/14767058.2012.703724.
  • 14.
    Zhang T, Zhang B, Zhao A, Chiu G. Clinical value of isolated intracardiac echogenic focus in the fetal heart: A retrospective study in Chinese women. Clin Experiment Obstet Gynecol. 2019;46(6):972-6. https://doi.org/10.12891/ceog5066.2019.
  • 15.
    Wang J, Chen L, Zhou C, Wang L, Xie H, Xiao Y, et al. Identification of copy number variations among fetuses with ultrasound soft markers using next-generation sequencing. Sci Rep. 2018;8(1):8134. [PubMed ID: 29802277]. [PubMed Central ID: PMC5970175]. https://doi.org/10.1038/s41598-018-26555-6.
  • 16.
    Philip S, Philip SE, Vaideeswar P, Singh UP. A Study on Fetal Intracardiac Echogenic Foci. J India Acad Echocardiograph Cardiovasc Imag. 2021;5(3):195-200. https://doi.org/10.4103/jiae.jiae_70_20.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles